Evidence map›Paper›PMID 41296606›Full record

ArticleJournal of clinical microbiology2025

Molecular diagnostics in cancer patients with suspected respiratory mold infections.

V Rickerts, J Springer, J Gerkrath, D Korczynski, J Kessel, I Wieters, T Liebregts, J Steinmann, O A Cornely, P Koehler and 14 more

Abstract readMulticenter StudyComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

V Rickerts *Robert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany.ORCID 0000-0002-6154-4920
J Springer *Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.
J GerkrathRobert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany.
D KorczynskiDepartment of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
J KesselMedical Clinic 2, Goethe University Frankfurt, Frankfurt, Hessen, Germany.
I WietersMedical Clinic 2, Goethe University Frankfurt, Frankfurt, Hessen, Germany.
T LiebregtsDepartment of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Nordrhein Westfalen, Germany.
J SteinmannInstitute of Medical Microbiology, Excellence Center for Medical Mycology (ECMM), University Hospital Essen, Essen, Nordrhein Westfalen, Germany.ORCID 0000-0002-3181-3667
O A CornelyInstitute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Nordrhein Westfalen, Germany.
P KoehlerInstitute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Nordrhein Westfalen, Germany.
S SchwartzDepartment of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany.
T ElgetiKlinik für Radiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany.
L MeintkerAbteilung für Innere Medizin 5, Uniklinikum Erlangen, Erlangen, Bayern, Germany.
S W KrauseAbteilung für Innere Medizin 5, Uniklinikum Erlangen, Erlangen, Bayern, Germany.
J HeldMikrobiologisches Institut-Klinische Mikrobiologie Immunologie und Hygiene, Universitätsklinik Erlangen und Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.ORCID 0000-0003-1130-9727
W J HeinzMedizinische Klinik 2, Caritas Hospital, Bad Mergentheim, Bayern, Germany.
B WillingerDivision of Clinical Microbiology, Department for Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
G MaschmeyerDepartment of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Brandenburg, Germany.
S VoigtRobert Koch-Institut, Unit 12: Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients, Berlin, Germany.
J ReicheRobert Koch-Institut, Unit 17: Influenza and Other Respiratory Viruses, Berlin, Germany.
J J VehreschildDepartment I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Nordrhein Westfalen, Germany.
H Einsele *Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.
D Teschner *Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.
J Löffler *Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.ORCID 0000-0001-6619-1100

Funding

Wilhelm Sander-Stiftung 2015.083.1
6 · The paper itself

Abstract

Invasive fungal infections (IFIs), including aspergillosis and mucormycosis, are serious complications in cancer patients. Reliable detection of etiologic agents is challenging but important for optimal patient management. In a prospective multicenter study, we compared fungal detection by culture, specific and unspecific qPCRs, and fluorescence

Indexed as

Molecular Diagnostic TechniquesNeoplasmsRespiratory Tract InfectionsAdultAgedAged, 80 and overAspergillusBronchoalveolar Lavage FluidDNA, FungalFemaleFungiHumansIn Situ Hybridization, FluorescenceInvasive Fungal InfectionsMaleMiddle AgedDNA, FungalAspergillosisBALFcancerCMVFISHmucormycosisPCR

Identifiers

PMID41296606
PMCPMC12710353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.